The9 Ltd
NCTY
Bit Digital
BTBT
TeraWulf
WULF
Digihost Technology
DGHI
BTCS Inc
BTCS
US Stock MarketDetailed Quotes
OLMA Olema Pharmaceuticals
- 4.200
- +0.060+1.45%
Close Mar 27 16:00 ET
- 4.400
- +0.200+4.76%
Post 20:01 ET
287.00MMarket Cap-1.91P/E (TTM)
4.225High4.020Low566.64KVolume4.150Open4.140Pre Close2.35MTurnover1.38%Turnover RatioLossP/E (Static)68.33MShares16.62052wk High0.70P/B172.65MFloat Cap3.93052wk Low--Dividend TTM41.11MShs Float60.270Historical High--Div YieldTTM4.95%Amplitude2.000Historical Low4.154Avg Price1Lot Size
About Olema Pharmaceuticals Company
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.
Company Profile
SymbolOLMA
Company NameOlema Pharmaceuticals
Listing DateNov 19, 2020
Issue Price19.00
Founded2006
CEODr. Sean P. Bohen, M.D.,PhD
MarketNASDAQ
Employees96
Fiscal Year Ends12-31
Address780 Brannan Street
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94103
Phone1-415-651-3316
Websitehttp://www.olema.com
Company Executives
- Name
- Position
- Salary
- Dr. Sean P. Bohen, M.D.,PhD
- Director, President and Chief Executive Officer
- 3.15M
- Dr. Naseem Zojwalla, M.D.
- Chief Medical Officer
- 1.30M
- Dr. David C. Myles, PhD
- Chief Discovery and Non-Clinical Development Officer
- --
- Shane Kovacs
- Principal Accounting Officer, Chief Operating and Financial Officer
- 1.55M
- Ian T. Clark
- Chairman of the Board
- 198.65K
- Dr. Cyrus L. Harmon, PhD
- Director
- 1.33M
- Yi Larson
- Independent Director
- 163.15K
- Cynthia M. Butitta
- Independent Director
- 180.15K
- Scott Garland
- Independent Director
- 280.21K
- Andrew S. Rappaport
- Independent Director
- 176.65K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 158.15K
- Dr. Graham Waley, M.D.,PhD
- Independent Director
- 171.15K
- Dr. Gorjan Hrustanovic, PhD
- Independent Director
- 165.15K
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.